Cordyceps militaris polysaccharide alleviates diabetic symptoms by regulating gut microbiota against TLR4/NF-KB pathway

The relationship between gut microbiota and type 2 diabetes mellitus (T2DM) has attracted increasing attention. In our work, one purified fraction a (AEPSa) was obtained from Cordyceps militaris polysaccharides, and its hypoglycemic activity and underlying mechanisms were investigated in high-fat diet (HFD)-and streptozotocin (STZ)-induced T2DM mice. The results revealed that AEPSa reshaped gut microbiota by increasing Allobaculum, Alistipes, Lachnospiraceae_NK4A136_group and norank_f_Muribaculaceae and decreasing Enterococcus and Rumino-coccus_torques_group to inhibit the colonic toll-like receptor 4 (TLR4)/nuclear factor kappa-B (NF -KB) pathway and upregulate intestinal tight junction protein expression, thereby improving glucose and serum lipid meta-bolism, hormone secretion and complications. Fecal microbiota transplantation (FMT) also confirmed these findings. These results indicated that symptomatic relief of T2DM might be related to AEPSa regulating the gut microbiota against the TLR4/NF-KB pathway to protect the intestinal barrier. Therefore, AEPSa might be developed as a prebiotic agent against T2DM by regulating gut microbiota.

Automated summary

In this study, it was found that AEPSa, a purified fraction from Cordyceps militaris polysaccharides, could improve the gut microbiota of T2DM mice induced by high-fat diet and streptozotocin. AEPSa reduced the activation of the colonic Toll-like receptor 4/nuclear factor kappa-B pathway, upregulated intestinal tight junction protein expression, and improved glucose and serum lipid metabolism, hormone secretion, and complications.